CID 470303

7-[4-[[(3z)-5-chloro-2-oxo-3-[4-(pyrimidin-2-ylsulfamoyl)phenyl]imino-indolin-1-yl]methyl]piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid

Structural Information

Molecular Formula
C35H30ClFN8O6S
SMILES
CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)CN4C5=C(C=C(C=C5)Cl)C(=NC6=CC=C(C=C6)S(=O)(=O)NC7=NC=CC=N7)C4=O)F)C(=O)O
InChI
InChI=1S/C35H30ClFN8O6S/c1-2-43-19-26(34(48)49)32(46)25-17-27(37)30(18-29(25)43)44-14-12-42(13-15-44)20-45-28-9-4-21(36)16-24(28)31(33(45)47)40-22-5-7-23(8-6-22)52(50,51)41-35-38-10-3-11-39-35/h3-11,16-19H,2,12-15,20H2,1H3,(H,48,49)(H,38,39,41)
InChIKey
OOLFWNJAJNCHGV-UHFFFAOYSA-N
Compound name
7-[4-[[5-chloro-2-oxo-3-[4-(pyrimidin-2-ylsulfamoyl)phenyl]iminoindol-1-yl]methyl]piperazin-1-yl]-1-ethyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

744.16815 Da
Monoisotopic Mass

2.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 745.17543 265.6
[M+Na]+ 767.15737 271.4
[M-H]- 743.16087 273.9
[M+NH4]+ 762.20197 257.6
[M+K]+ 783.13131 263.6
[M+H-H2O]+ 727.16541 251.4
[M+HCOO]- 789.16635 263.6
[M+CH3COO]- 803.18200 266.5
[M+Na-2H]- 765.14282 264.3
[M]+ 744.16760 268.9
[M]- 744.16870 268.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.